Nuclear medicine in urological cancers: what is new? - Wikidata - wikimedia - TriplyDB

Nuclear medicine in urological cancers: what is new?

Nuclear medicine in urological cancers: what is new?

http://www.wikidata.org/entity/Q38268168

about

PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.

P2860

Q38389152-F01BDC53-C278-4202-A767-93877E1E74D2

P2860

Nuclear medicine in urological cancers: what is new?

http://www.wikidata.org/entity/Q38268168

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Nuclear medicine in urological cancers: what is new?

@en

type

label

Nuclear medicine in urological cancers: what is new?

@en

prefLabel

Nuclear medicine in urological cancers: what is new?

@en

P1433

Q38268168-F5E61343-1066-4A1F-AF32-D303C06A3F75

P1476

Q38268168-075AF862-3DAB-4016-BE0A-3633D06E7113

P2093

Q38268168-674624E0-8545-4060-8AE9-98EA1F7A45B7

Q38268168-A033E96A-5A63-4505-9ADB-994D14A276D6

P2860

Q38268168-0253EBBA-7769-4994-8950-513462A393C3

Q38268168-0CE68F89-63B8-4B64-AE63-4564FA0416CE

Q38268168-1486A89E-A36F-4195-AEB7-152BCD153DFB

Q38268168-14DBDF58-C9FC-42A0-A68B-FB52B0BFFF5A

Q38268168-184CD231-E6C9-431B-AF2E-B145C3BE643F

Q38268168-1E30AF26-701C-445B-A689-03AA101DC47A

Q38268168-1F1092C5-E609-4A7B-9E33-A6AF1D5225A6

Q38268168-2648CC02-0455-42DB-AF9B-C7DF52A830DF

Q38268168-341BBFF5-79C0-4284-BC4B-0636ED61F218

Q38268168-359CEBB0-276E-4030-A404-A3B8F62E45B4

P304

Q38268168-381B3850-2C43-480C-B40A-D4E28DC6B6DF

P31

Q38268168-356ADD7F-24C1-462B-B12B-8A2DF8D19A75

P356

Q38268168-F1952035-2383-4579-BA44-9C3B8FE09D12

P407

Q38268168-3DFD8694-1F6C-4845-B6AD-6CA1826BED58

P433

Q38268168-92F6AE26-9F24-4AD2-AC18-10FAEAE57D44

P478

Q38268168-5245C53C-9D61-4856-8DFD-D282B4EFB4F2

P50

Q38268168-B8EE9AEB-A425-4E20-8053-C4BB27D02031

P577

Q38268168-339118D6-BA89-4CF9-A8BF-8F6C1B53BEFF

P698

Q38268168-8C771988-A594-4C83-ACEA-908DA7F9C09A

P356

P1433

Future Oncology

P1476

Nuclear medicine in urological cancers: what is new?

@en

P2093

Cristina Nanni

http://www.w3.org/2001/XMLSchema#string

Lucia Zanoni

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Detection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPET

Imaging of advanced renal cell carcinoma.

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.

Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT

Positron emission tomography for urological tumours.

Positron emission tomography for prostate, bladder, and renal cancer.

Renal cell carcinoma: current status and future prospects.

Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.

P304

2061-2072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.14.87

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25396777

http://www.w3.org/2001/XMLSchema#string